Johnson & Johnson (J&J) has received approval from the European Commission (EC) for its subcutaneous (SC ... patients who are eligible or ineligible for an autologous stem-cell transplant (ASCT). The ...

“The subcutaneous daratumumab-VRd regimen delivers an effective ... in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy.

As we announced today, there has been a tremendous amount of activity moving us toward approval of narsoplimab for hematopoietic stem cell transplant ... take a pill or a subcutaneous injection ...

Belgium: Janssen-Cilag International NV, a Johnson & Johnson company, has received approval from the European Commission (EC) for an indication extension of DARZALEX (daratumumab) subcutaneous ... for ...

Stem cell-derived pancreatic islets are being studied as a rich transplantable source for insulin production, a therapeutic ...

One continuing challenge is the need to suppress transplant patients' immune systems to prevent their bodies from rejecting ...

Understanding how cells differentiate during early embryonic development is crucial for advancing regenerative medicine and ...

In a new study, researchers from the University of Copenhagen have successfully created stem cells that are better at developing into other cell types, like a younger, fitter version of themselves ...

Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might ...

Restoring those stem cells by growing them in a lab can treat the cell deficiency that gives rise to corneal blood vessel growth, cloudiness and pain, Jurkunas said. Jurkunas said the transplant ...